Tempo Bioscience Expands Human Liver Models for Toxicity Evaluation and Disease Modeling
SAN FRANCISCO--(BUSINESS WIRE)--Tempo Bioscience, Inc. (“Tempo”), a privately-held biotechnology company based in San Francisco, California, has released new human induced pluripotent stem cell (iPSC) derived cell products and affiliated cell-based services in the following categories: Tempo-iHepStellate™ Human iPSC-derived Hepatic Stellate Cells Tempo-iKupffer™ Human iPSC-derived Kupffer Cells Tempo-iLSEC™ Human iPSC-derived Liver...
